In fact, the ROS modulator and anti-inflammatory effects of Lf may serve as a possible protective mechanism against AD by modulating the phosphorylated protein kinase B (p-PKB/AKT)/phosphatase and tensin homolog (PTEN) pathway; this possibility was investigated and confirmed in the AD patients [87]. Here, AKT1 is linked to Alzheimer disease.